Dementia is a growing health concern – there are almost 1 million people in the UK who have dementia[i] and it is the leading cause of death in the UK.[ii] Within hospitals, a quarter of beds are ...
Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar ...